Phase I trial of selenium plus chemotherapy in gynecologic cancers

PURPOSE: Preclinical studies performed in our laboratory have shown that high-dose selenium inhibits the development of carboplatin drug resistance in an ovarian cancer mouse xenograft model. Based on these data, as well as the potential serious toxicities of supranutritional doses of selenium, a ph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Song, Mihae, Kumaran, Muthu N., Gounder, Murugesan, Gibbon, Darlene G., Nieves-Neira, Wilberto, Vaidya, Ami, Hellmann, Mira, Kane, Michael P., Buckley, Brian, Shih, Weichung, Caffrey, Paula B., Frenkel, Gerald D., Rodriguez-Rodriguez, Lorna
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154492/
https://ncbi.nlm.nih.gov/pubmed/30068487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.07.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados